Chambal Fertilizers & Chemicals Ltd.
CHAMBLFERTCommodities filings
We hold this company’s filings and have not read the financial statements out of them yet. Every filing on record is listed under filings, and each one opens.
Earnings calls
18 transcript(s)/analyst meet(s) served; 0 document(s) on file are not transcripts (cover letters, duplicates, unresolved) and are excluded. Speaker attribution is shown only where the segmenter attributes ≥ 95% of sentences to management or analysts (0 of 18 documents here); elsewhere sentences render unattributed.
| Kind | Date | Period | Served | Attribution rate |
|---|---|---|---|---|
| TRANSCRIPT | 20220524 | 2022-03-31 | yes | |
| TRANSCRIPT | 20220810 | 2022-06-30 | yes | |
| TRANSCRIPT | 20221108 | 2022-09-30 | yes | |
| TRANSCRIPT | 20230213 | 2022-12-31 | yes | |
| TRANSCRIPT | 20230602 | 2023-03-31 | yes | |
| TRANSCRIPT | 20230814 | 2023-06-30 | yes | |
| TRANSCRIPT | 20231110 | 2023-09-30 | yes | |
| TRANSCRIPT | 20240213 | 2023-12-31 | yes | |
| TRANSCRIPT | 20240515 | 2024-03-31 | yes | |
| TRANSCRIPT | 20240813 | 2024-06-30 | yes | |
| TRANSCRIPT | 20241113 | 2024-09-30 | yes | |
| TRANSCRIPT | 20250212 | 2024-12-31 | yes | |
| TRANSCRIPT | 20250516 | 2025-03-31 | yes | |
| TRANSCRIPT | 20250807 | 2025-06-30 | yes | |
| TRANSCRIPT | 20251113 | 2025-09-30 | yes | |
| TRANSCRIPT | 20260218 | 2025-12-31 | yes | |
| TRANSCRIPT | 20260520 | 2026-03-31 | yes | |
| TRANSCRIPT | 20260806 | 2026-06-30 | yes |
CHAMBLFERT
files the standard Schedule III statements. Every figure below opens to the filing it was read from; where a figure is not shown, the reason is printed in its place.
Identity
| Statement division | general |
| Scope served | consolidated |
| Panels on this page | 4 |
Market
No split, bonus or consolidation is on record for this company inside the period this price series covers, so the closes need no adjustment.
| Last close | 418.20 |
| 52-week range | 409.1 – 532.8 |
| Return 1M | -2.2% |
| Return 3M | -10.84% |
| Return 1Y | -21.51% |
| Return 3Y | 48.8% |
| Return 5Y | 22.59% |
| Market capitalisation | not shown — we could not confirm it |
| Shares outstanding | not shown — we could not confirm it |
| P/E | not shown — we could not confirm it |
| P/B | not shown — we could not confirm it |
| EV/EBITDA | not shown — we could not confirm it |
Latest quarter filed — period ending 2026-06-30
In INR crore except per-share figures. `period_id` is the period the filing names for the number; the date beside each cell is when it was filed.
| Revenue from operations | 5,027.00 |
| Other income | 27.00 |
| Total income | 5,054.00 |
| Cost of materials consumed | 1,482.00 |
| Purchases of stock-in-trade | 2,441.00 |
| Changes in inventories | -944.00 |
| Employee benefit expense | 70.00 |
| Finance costs | 17.00 |
Ownership — 2026-06-30, and the change from 2026-03-31
| Holder | Per cent | Change |
|---|---|---|
| promoter and promoter group | 0.61 | 0.00 |
| institutions foreign | 0.15 | -0.00 |
| institutions domestic | 0.05 | -0.00 |
| mutual funds | 0.05 | -0.00 |
| public | 0.39 | -0.00 |
Documents on file
| Class | Most recent | On file |
|---|---|---|
| TRANSCRIPT | 2026-06-30 | 18 |
Financial statements
Filed results, consolidated, in INR crore except per-share figures. Every figure opens to the filing it was read from. Quarterly and annual columns are the periods the filing itself names, never a document date.
Quarterly results, as filed
| Line | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | 2024-12-31 | 2025-03-31 | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 8,587.00 | 8,296.00 | 3,599.00 | 5,589.00 | 5,386.00 | 4,349.00 | 2,643.00 | 4,933.00 | 4,346.00 | 4,918.00 | 2,449.00 | 5,698.00 | 6,413.00 | 5,898.00 | 2,785.00 | 5,027.00 |
| Other income | 89.00 | 23.00 | 41.00 | 9.00 | 82.00 | 95.00 | 63.00 | 51.00 | 44.00 | 65.00 | 55.00 | 43.00 | 41.00 | 14.00 | 29.00 | 27.00 |
| Total income | 8,676.00 | 8,319.00 | 3,640.00 | 5,598.00 | 5,467.00 | 4,444.00 | 2,706.00 | 4,984.00 | 4,390.00 | 4,983.00 | 2,504.00 | 5,741.00 | 6,453.00 | 5,912.00 | 2,814.00 | 5,054.00 |
| Cost of materials consumed | 2,563.00 | 2,269.00 | 1,633.00 | 1,682.00 | 1,680.00 | 1,869.00 | 1,350.00 | 1,754.00 | 1,792.00 | 1,597.00 | 1,292.00 | 1,504.00 | 1,522.00 | 1,612.00 | 1,321.00 | 1,482.00 |
| Purchases of stock-in-trade | 4,168.00 | 1,692.00 | 865.00 | 2,891.00 | 234.00 | 600.00 | 450.00 | 974.00 | 694.00 | 751.00 | 1,008.00 | 2,284.00 | 2,969.00 | 1,790.00 | 742.00 | 2,441.00 |
| Changes in inventories | -420.00 | 2,016.00 | -290.00 | -937.00 | 1,503.00 | -32.00 | -388.00 | 165.00 | -201.00 | 595.00 | -1,104.00 | -90.00 | -162.00 | 402.00 | -600.00 | -944.00 |
| Employee benefit expense | 50.00 | 48.00 | 49.00 | 54.00 | 53.00 | 56.00 | 57.00 | 56.00 | 58.00 | 58.00 | 62.00 | 62.00 | 64.00 | 95.00 | 66.00 | 70.00 |
| Finance costs | 85.00 | 120.00 | 67.00 | 55.00 | 46.00 | 36.00 | 36.00 | 40.00 | 1.00 | 7.00 | 0.00 | 2.00 | 1.00 | 1.00 | 3.00 | 17.00 |
| Depreciation and amortisation | 78.00 | 78.00 | 76.00 | 77.00 | 78.00 | 79.00 | 78.00 | 82.00 | 83.00 | 83.00 | 82.00 | 84.00 | 87.00 | 88.00 | 90.00 | 89.00 |
| Other expenses | 1,780.00 | 1,602.00 | 1,230.00 | 1,266.00 | 1,300.00 | 1,226.00 | 1,008.00 | 1,232.00 | 1,214.00 | 1,139.00 | 1,028.00 | 1,177.00 | 1,178.00 | 1,179.00 | 1,001.00 | 1,127.00 |
| Total expenses | 8,305.00 | 7,824.00 | 3,630.00 | 5,088.00 | 4,895.00 | 3,836.00 | 2,591.00 | 4,304.00 | 3,641.00 | 4,230.00 | 2,367.00 | 5,024.00 | 5,659.00 | 5,166.00 | 2,623.00 | 4,282.00 |
| Profit before exceptional items and tax | 370.00 | 495.00 | 10.00 | 510.00 | 573.00 | 608.00 | 115.00 | 681.00 | 750.00 | 753.00 | 137.00 | 717.00 | 795.00 | 746.00 | 191.00 | 772.00 |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 370.00 | 495.00 | 10.00 | 510.00 | 573.00 | 608.00 | 115.00 | 681.00 | 750.00 | 753.00 | 137.00 | 717.00 | 795.00 | 746.00 | 191.00 | 772.00 |
| Current tax | 44.00 | 80.00 | -8.00 | 103.00 | 90.00 | 96.00 | 9.00 | 135.00 | 122.00 | 156.00 | 41.00 | 228.00 | 227.00 | 208.00 | 96.00 | 211.00 |
| Deferred tax | 86.00 | 91.00 | -79.00 | 74.00 | 110.00 | 108.00 | 20.00 | 132.00 | 127.00 | 92.00 | -3.00 | -23.00 | -34.00 | -26.00 | -50.00 | 13.00 |
| Tax expense | 130.00 | 171.00 | -88.00 | 177.00 | 200.00 | 205.00 | 29.00 | 268.00 | 249.00 | 248.00 | 37.00 | 205.00 | 193.00 | 182.00 | 46.00 | 223.00 |
| Profit for the period | 274.00 | 324.00 | 94.00 | 339.00 | 381.00 | 459.00 | 97.00 | 448.00 | 536.00 | 534.00 | 130.00 | 549.00 | 649.00 | 586.00 | 169.00 | 524.00 |
| Profit attributable to owners | 274.00 | 324.00 | 94.00 | 339.00 | 381.00 | 459.00 | 97.00 | 448.00 | 536.00 | 534.00 | 130.00 | 549.00 | 649.00 | 586.00 | 169.00 | 524.00 |
| Profit attributable to non-controlling interests | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Other comprehensive income | -18.00 | 2.00 | 48.00 | 45.00 | -3.00 | 32.00 | 32.00 | 17.00 | 49.00 | -1.00 | 60.00 | 60.00 | 52.00 | -3.00 | 16.00 | 20.00 |
| Total comprehensive income | 256.00 | 326.00 | 142.00 | 384.00 | 378.00 | 491.00 | 129.00 | 465.00 | 585.00 | 534.00 | 190.00 | 609.00 | 701.00 | 583.00 | 185.00 | 544.00 |
| Earnings per share, basic | 6.59 | 7.79 | 2.26 | 8.14 | 9.15 | 11.04 | 2.51 | 11.19 | 13.39 | 13.34 | 3.25 | 13.70 | 16.19 | 14.64 | 4.23 | 13.07 |
| Earnings per share, diluted | 6.59 | 7.79 | 2.26 | 8.14 | 9.15 | 11.04 | 2.51 | 11.19 | 13.39 | 13.34 | 3.25 | 13.70 | 16.19 | 14.64 | 4.23 | 13.07 |
Annual results, as filed
| Line | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 |
|---|---|---|---|---|---|---|---|
| Revenue from operations | 12,206.00 | 12,719.00 | 16,069.00 | 27,773.00 | 17,966.00 | 16,646.00 | 20,794.00 |
| Other income | 107.00 | 37.00 | 68.00 | 168.00 | 249.00 | 215.00 | 127.00 |
| Total income | 12,313.00 | 12,756.00 | 16,137.00 | 27,941.00 | 18,216.00 | 16,861.00 | 20,921.00 |
| Cost of materials consumed | 3,773.00 | 2,924.00 | 5,369.00 | 8,523.00 | 6,582.00 | 6,435.00 | 5,959.00 |
| Purchases of stock-in-trade | 2,907.00 | 4,060.00 | 6,562.00 | 9,396.00 | 4,175.00 | 3,426.00 | 7,785.00 |
| Changes in inventories | 209.00 | 354.00 | -2,327.00 | 1,786.00 | 145.00 | -545.00 | -450.00 |
| Employee benefit expense | 156.00 | 176.00 | 181.00 | 191.00 | 221.00 | 233.00 | 287.00 |
| Finance costs | 503.00 | 279.00 | 106.00 | 320.00 | 173.00 | 48.00 | 7.00 |
| Depreciation and amortisation | 287.00 | 289.00 | 300.00 | 308.00 | 313.00 | 330.00 | 349.00 |
| Other expenses | 3,258.00 | 2,741.00 | 4,023.00 | 6,058.00 | 4,800.00 | 4,613.00 | 4,535.00 |
| Total expenses | 11,093.00 | 10,824.00 | 14,212.00 | 26,582.00 | 16,409.00 | 14,541.00 | 18,471.00 |
| Profit before exceptional items and tax | 1,219.00 | 1,932.00 | 1,925.00 | 1,359.00 | 1,807.00 | 2,320.00 | 2,450.00 |
| Exceptional items | 106.00 | 338.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 1,325.00 | 2,270.00 | 1,925.00 | 1,359.00 | 1,807.00 | 2,320.00 | 2,450.00 |
| Current tax | 187.00 | 330.00 | 337.00 | 209.00 | 299.00 | 455.00 | 759.00 |
| Deferred tax | -86.00 | 282.00 | 328.00 | 174.00 | 312.00 | 348.00 | -134.00 |
| Tax expense | 101.00 | 612.00 | 665.00 | 383.00 | 611.00 | 802.00 | 625.00 |
| Profit for the period | 1,226.00 | 1,748.00 | 1,566.00 | 1,034.00 | 1,276.00 | 1,649.00 | 1,953.00 |
| Profit attributable to owners | 1,226.00 | 1,655.00 | 1,566.00 | 1,034.00 | 1,276.00 | 1,650.00 | 1,953.00 |
| Profit attributable to non-controlling interests | -1.00 | 93.00 | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Other comprehensive income | -282.00 | 179.00 | -43.00 | -56.00 | 106.00 | 125.00 | 125.00 |
| Total comprehensive income | 943.00 | 1,927.00 | 1,523.00 | 978.00 | 1,382.00 | 1,774.00 | 2,079.00 |
| Earnings per share, basic | 29.46 | 39.76 | 37.62 | 24.85 | 30.84 | 41.17 | 48.76 |
| Earnings per share, diluted | 29.46 | 39.76 | 37.62 | 24.85 | 30.84 | 41.17 | 48.76 |
Balance sheet, as filed
| Line | 2022-09-30 | 2023-03-31 | 2023-09-30 | 2024-03-31 | 2024-09-30 | 2025-03-31 | 2025-09-30 | 2026-03-31 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 18,981.00 | 12,770.00 | 13,663.00 | 11,509.00 | 12,498.00 | 11,407.00 | 13,853.00 | 14,402.00 |
| Non-current assets | 7,117.00 | 7,131.00 | 6,977.00 | 7,420.00 | 7,518.00 | 7,785.00 | 8,109.00 | 8,440.00 |
| Current assets | 11,864.00 | 5,638.00 | 6,683.00 | 4,086.00 | 4,977.00 | 3,622.00 | 5,743.00 | 5,961.00 |
| Property, plant and equipment | 6,350.00 | 6,261.00 | 6,171.00 | 6,419.00 | 6,304.00 | 6,218.00 | 6,084.00 | 6,102.00 |
| Capital work-in-progress | 72.00 | 102.00 | 95.00 | 184.00 | 298.00 | 649.00 | 1,135.00 | 1,389.00 |
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other intangible assets | 2.00 | 1.00 | 3.00 | 3.00 | 4.00 | 3.00 | 3.00 | 8.00 |
| Inventories | 3,077.00 | 1,374.00 | 806.00 | 1,255.00 | 1,296.00 | 1,802.00 | 2,069.00 | 2,280.00 |
| Trade receivables | 8,152.00 | 1,760.00 | 891.00 | 192.00 | 422.00 | 368.00 | 2,260.00 | 2,075.00 |
| Cash and cash equivalents | 40.00 | 37.00 | 493.00 | 110.00 | 45.00 | 108.00 | 141.00 | 308.00 |
| Total equity and liabilities | 18,981.00 | 12,770.00 | 13,663.00 | 11,509.00 | 12,498.00 | 11,407.00 | 13,853.00 | 14,402.00 |
| Equity | 6,773.00 | 7,053.00 | 7,690.00 | 7,258.00 | 8,188.00 | 8,712.00 | 9,822.00 | 10,390.00 |
| Equity share capital | 416.00 | 416.00 | 416.00 | 401.00 | 401.00 | 401.00 | 401.00 | 401.00 |
| Other equity | 6,371.00 | 6,652.00 | 7,289.00 | 6,873.00 | 7,803.00 | 8,327.00 | 9,438.00 | 10,007.00 |
| Total liabilities | 12,208.00 | 5,717.00 | 5,973.00 | 4,251.00 | 4,310.00 | 2,695.00 | 4,031.00 | 4,013.00 |
| Non-current liabilities | 2,952.00 | 2,565.00 | 2,421.00 | 2,214.00 | 1,404.00 | 1,521.00 | 1,504.00 | 1,457.00 |
| Current liabilities | 9,257.00 | 3,152.00 | 3,552.00 | 2,037.00 | 2,906.00 | 1,174.00 | 2,528.00 | 2,555.00 |
| Borrowings, non-current | 2,228.00 | 1,820.00 | 1,490.00 | 1,144.00 | 81.00 | 82.00 | 86.00 | 91.00 |
| Borrowings, current | 4,690.00 | 1,515.00 | 791.00 | 709.00 | 0.00 | 0.00 | 0.00 | 963.00 |
| Trade payables | 4,155.00 | 1,212.00 | 1,122.00 | 794.00 | 2,040.00 | 630.00 | 1,792.00 | 936.00 |
Cash flow, as filed
| Line | 2022-09-30 | 2023-03-31 | 2023-09-30 | 2024-03-31 | 2024-09-30 | 2025-03-31 | 2025-09-30 | 2026-03-31 |
|---|---|---|---|---|---|---|---|---|
| Net cash from operating activities | -2,600.00 | 3,239.00 | 3,808.00 | 3,327.00 | 2,746.00 | 1,394.00 | 347.00 | 138.00 |
| Net cash from investing activities | 6.00 | -1,873.00 | -2,038.00 | -382.00 | -876.00 | 739.00 | -110.00 | -482.00 |
| Net cash from financing activities | 2,101.00 | -1,862.00 | -1,314.00 | -2,871.00 | -1,935.00 | -2,135.00 | -203.00 | 543.00 |
| Purchase of property, plant and equipment | 89.00 | 197.00 | 222.00 | 610.00 | 220.00 | 572.00 | 487.00 | 886.00 |
| Net increase in cash | -492.00 | -495.00 | 456.00 | 73.00 | -65.00 | -2.00 | 33.00 | 200.00 |
| con:CFO.BEFORE_TAX | -2,446.00 | 3,511.00 | 3,941.00 | 3,671.00 | 2,875.00 | 1,782.00 | 641.00 | 852.00 |
| con:INTEREST_RECEIVED.OPERATING | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:INTEREST_PAID.OPERATING | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:DIVIDENDS_RECEIVED.OPERATING | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:TAX_PAID.OPERATING | 154.00 | 271.00 | 132.00 | 345.00 | 129.00 | 388.00 | 294.00 | 715.00 |
| con:CF_OTHER.OPERATING | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:INVESTMENTS_PURCHASED | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:INVESTMENTS_SOLD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:PPE_DISPOSALS | 1.00 | 4.00 | 2.00 | 3.00 | 0.00 | 3.00 | 1.00 | 1.00 |
| con:CF_INVESTING.SUBSIDIARIES_SOLD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:CF_INVESTING.SUBSIDIARIES_ACQUIRED | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:CF_INVESTING.JV_SOLD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:CF_INVESTING.JV_ACQUIRED | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Who owns it
The shareholding pattern filed with the exchange every quarter, as a series. Percentages are of total shares. Each figure names the filing it was read from and the date it was filed.
| Holder | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-02-13 | 2024-03-31 | 2024-06-30 | 2024-09-30 | 2024-12-31 | 2025-03-31 | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoter and promoter group | 60.56 | 60.56 | 60.56 | 60.70 | 60.70 | 60.70 | 60.40 | 60.40 | 60.40 | 60.50 | 0.61 | 0.61 | 0.61 | 0.61 |
| Domestic institutions | 11.97 | 9.03 | 9.34 | 6.69 | 7.06 | 7.29 | 6.87 | 5.83 | 4.59 | 6.55 | 0.04 | 0.05 | 0.05 | 0.05 |
| Mutual funds | — | — | — | — | — | — | — | — | — | 6.40 | 0.04 | 0.04 | 0.05 | 0.05 |
| Insurance companies | 0.38 | 0.32 | 0.25 | 0.25 | 0.26 | 0.35 | 0.30 | 0.20 | 0.03 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 |
| Foreign institutions | 9.64 | 10.84 | 13.40 | 13.90 | 15.00 | 15.60 | 15.35 | 18.15 | 20.19 | 17.11 | 0.18 | 0.16 | 0.15 | 0.15 |
| Government | — | — | — | — | — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 |
| Public | 39.44 | 39.44 | 39.44 | 39.30 | 39.30 | 39.30 | 39.60 | 39.60 | 39.60 | 39.50 | 0.39 | 0.39 | 0.39 | 0.39 |
| Non-institutional | 17.83 | 19.56 | 16.70 | 18.71 | 17.24 | 16.40 | 17.37 | 15.62 | 14.82 | 15.83 | 0.17 | 0.19 | 0.18 | 0.18 |
| Shares outstanding | 416207852 | 416207852 | 416207852 | 400652297 | 400652297 | 400652297 | 400652297 | 400652297 | 400652297 | 400652297 | 400652297 | 400652297 | 400652297 | 400652297 |
Related parties
Transactions with related parties as disclosed to the exchange for the period ending 2024-09-30, by counterparty, largest first. Amounts are as filed. Each row names the filing and the date it was filed.
| Counterparty | Relationship | Type | Amount in the period | Transactions |
|---|---|---|---|---|
| Indo Maroc Phosphore, S.A. - IMACID | Joint Venture | Any other transaction, Dividend received | 1,390,600,000.00 | 2 |
| CFCL Employees Group Gratuity Scheme | Post Employment Benefit Plan | Any other transaction | 177,000,000.00 | 1 |
| Mr. Abhay Baijal | Managing Director | Any other transaction, Remuneration | 18,000,000.00 | 2 |
| Mr. Anand Agarwal | Chief Financial Officer | Remuneration | 14,600,000.00 | 1 |
| Mr. Tridib Barat | Company Secretary | Remuneration | 7,500,000.00 | 1 |
| ISGN Corporation | Subsidiary Company | Advance | 1,200,000.00 | 1 |
| Lionel India Limited | Promoter Group | Purchase of goods or services | 600,000.00 | 1 |
| Zuari Finserv Limited | Promoter Group | Purchase of goods or services | 400,000.00 | 1 |
| Mr Manoj Bawa | Director of Subsidiary | Any other transaction | 400,000.00 | 1 |
| Mr. Pradeep Jyoti Banerjee | Independent - Non-Executive Direct | Any other transaction | 300,000.00 | 2 |
| Ms. Rita Menon | Independent - Non-Executive Direct | Any other transaction | 300,000.00 | 2 |
| Mr. Vivek Mehra | Independent - Non-Executive Direct | Any other transaction | 200,000.00 | 2 |
| Mr. Berjis Minoo Desai | Independent - Non-Executive Direct | Any other transaction | 200,000.00 | 2 |
| Mr. Lee Kuan Jen Sebastian | Independent - Non-Executive Direct | Any other transaction | 200,000.00 | 1 |
| India Steamship Staff Provident Fund | Post Employment Benefit Plan | Any other transaction | 100,000.00 | 1 |
What management said
Every earnings call we hold for this company, read in full. Prepared remarks are separated from the question-and-answer session and every paragraph names who said it and on which page. These are management’s own words, not filed figures.
| Date | Quarter | Who spoke | |
|---|---|---|---|
| 2026-08-06 | Q1FY27 | Read the call | |
| 2026-05-20 | Q4FY26 | Read the call | |
| 2026-02-18 | Q3FY26 | Read the call | |
| 2025-11-13 | Q2FY26 | Read the call | |
| 2025-08-07 | Q1FY26 | Read the call | |
| 2025-05-16 | Q4FY25 | Read the call | |
| 2025-02-12 | Q3FY25 | Read the call | |
| 2024-11-13 | Q2FY25 | Read the call | |
| 2024-08-13 | Q1FY25 | Read the call | |
| 2024-05-15 | Q4FY24 | Read the call | |
| 2024-02-13 | Q3FY24 | Read the call | |
| 2023-11-10 | Q2FY24 | Read the call | |
| 2023-08-14 | Q1FY24 | Read the call | |
| 2023-06-02 | Q4FY23 | Read the call | |
| 2023-02-13 | Q3FY23 | Read the call | |
| 2022-11-08 | Q2FY23 | Read the call | |
| 2022-08-10 | Q1FY23 | Read the call | |
| 2022-05-24 | Q4FY22 | Read the call |
What they said about it, quarter by quarter
| Topic | Q3FY24 | Q3FY25 | Q3FY26 | Q4FY22 | Q4FY23 | Q4FY24 | Q4FY25 | Q4FY26 |
|---|---|---|---|---|---|---|---|---|
| Capex | Ramesh, your question regarding the CAPEX and the capital employed has already been answered by Mr. Baijal. | All of that is contributing to the growth and government's CAPEX investments also helps as it is mostly infrastructure related. | — | I had my first question on the CAPEX plan, Rs. | And sir, what kind of CAPEX are we targeting in the segment in FY24? | And for FY-25, what would be the capex plan? | In FY '25, what is the total CAPEX apart from TAN? | I think in the last Con Call, you touched upon a new Capex that we could be looking at, and a substantial Capex. |
| Capital allocation | — | Okay, so dividend receipt and all those things will continue as they are continuing. | So, at the moment, asset acquisition on this side is not really on the table, but this way, where we get, again, a TERI kind of model, where we get st… | — | — | — | But most of the time, when you do the math in terms of acquisition cost versus the return that you will expect, the returns come out to be lower than … | Board of Directors has recommended a final dividend of Rs. |
| Costs | And how does it help in terms of the back integration, especially when you look at backward integration where the benefit of the savings on input cost… | — | — | — | This is a part of raw materials, this impact? | So, there is abundant raw material available to take that. | So the dynamics keep changing, but I am confident that overall the supply situation in the world is steady, although because of the geographical inten… | We also secured product availability for upcoming Kharif season despite continued uncertainty in global, raw material market and supply chains. |
| Debt and cash | — | And how much is the net debt at the end of Q3 or net cash? | Already they have a mechanism, and with that mechanism, DAP, has worked so far, although there are now increasing difficulties in terms of working cap… | Like we've mentioned, we are in the technical bid stage right now and we would expect certain cash flows to start happening within this financial year… | 500 crore of cash flow on the TAN project specifically. | — | I just wanted to know where does our net debt stand as of 31st March net debt of cash? | Overall, FY '26 reflected resilient execution across our core and value-added businesses, despite a volatile global operating environment, while the u… |
| Demand | Seed to Harvest is a farmer connect and in a sense, explaining the advantage of certain types of molecules and new molecules, plus also developing a p… | So, currently, what could be the domestic demand for TAN and how much of it is being imported? | For Chambal, this translated into a stable outlook, with urea continuing to anchor volumes and cash flows and DAP and NPK providing diversification an… | All this translates to increased demand and consumption for Fertilizers, Crop Protection Chemicals and Agri Inputs. | You seem to have a bit of a hops and choice in terms of imports and subsidies, all moving in different lags, is the supply chain now in a portion wher… | Demand as I understand, is growing at 6% CAGR. | There is a pipeline of such energy efficient projects which also have knock-on benefits in terms of volume increases, because sometimes these projects… | Sales volume also rose to 0.65 lakh metric tons compared to 0.38 lakh metric tons with strong demand and steady increasing adoption of balanced fertil… |
| Guidance | Sir, some sense on outlook for IMACID for Q4, given that phosphatic prices have been more or less at the same level vis-a-vis Q3. I don't know how muc… | How much CAPEX do we expect to incur in this expansion? | — | As per India Metrological Department, the probability for a normal monsoon is 40% and we expect that the normal monsoon will then help the agriculture… | We expect that IMACID should continue to perform as per its standard past year performance in FY24. In FY '21, '22, there was a huge upsurge because o… | And because of the subsidies also decreased, so do we expect the same to continue in FY25? | So, we expect a robust growth in CPC segment overall. | So, is there any further guidance you would like to give on the same? |
| Margin | How much was the EBITDA or profit swing versus last year on the traded fertilizer business? | Seeing your EBITDA per ton for traded fertilizer, it does not look like we are making money on DAP. | EBITDA for the quarter was INR 821 crores, up 6%, despite taking a hit of INR 31 crores on account of labor codes, with EBITDA margins at 13.92%. | If you look at your fourth quarter performance, can you shed some light on how have you achieved this growth in EBITDA versus primarily on the Urea bu… | This is reflecting in the gross margin as such. | But the profitability difference will be only in Gadepan-III, because that is the only plant where we have higher profit margin per ton, right? | And you have given the gross margin, so what will be the EBITDA margin in percentage terms? | 255 crores, up 56% year-on-year with EBITDA margin at 9.16%. |
| People | See, this is a formula driven business where a percentage of the lower gas utilization helps earn additional margins as efficiency gains. | Sir, in the TAN project, if I may ask, if you look at the long-run economics of that business, what is the utilization you require to get your thresho… | Should we see a 70%-80% or even a higher kind of a utilization? | The first is that actually during this period of Feb-March-April, the actual utilization of fertilizer going into the soil is very very low. | — | So, the utilization will be lower in FY-25 compared to FY-24. | Just trying to get a number on what kind of revenues and EBITDAs can we see once this TAN project is getting commissioned and is being utilized to be … | Would we be able to reach a 60%-70% or even higher utilization in the first year itself? |
| Pricing | And how do you see the business moving, over the next four quarters, given the kind of uncertainty on the de-stocking related pressures and the pricin… | — | That's okay, but the very large quantity or large price increase in DAP, it went as high as $850 or something like that. | Can you provide, given the kind of heightened pricing levels of the P&K fertilizers and the better monsoon as well as Kharif expected to be better, co… | — | And any pricing of the product, how is that priced? | — | What we are going to tell them, in fact, what the industry is continuously telling them, is that there has been a dollar increase, there is a gas pric… |
| Revenue growth | See, if you look at the Investor Presentation, we have mentioned a top line of approx. INR 1,750 crore from the segment in year '26-'27 with a contrib… | And to the extent that there could be some continued pressure on pricing, what would be the revenue growth on a given volume growth? | — | — | So, we have more than doubled our top line over the last two years. | And the underlying growth of urea is between 1.5% to 2% CAGR which means that every year, you add about 600,000 to 700,000 tons of consumption. | So if you look at the 4th Quarter in terms of this crop protection revenue growth, how much of that will be volume growth versus other companies are t… | Complex fertilizer segment continued to outperform during FY '26, with revenues increasing sharply to INR 7,025 crores, reflecting year-on-year growth… |